Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-04 · accession 0001209191-21-059516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-05 | 2021-10-04 | CCCC | COHEN ALAIN J | Dir | A - Grant | $44.99 | +222 | 222 | New | +$9,988 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | A | A | 222 | $44.99 | 222 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021. (F3) This amount has been adjusted to reflect 517 shares previously transferred from the Reporting Person to the Alain J. Cohen Revocable Trust. |